Nuvo establishes a new category of clinician-connected, at-home/work pregnancy monitoring with its INVU(TM) wearable solution to provide pregnant moms with reassurance between prenatal visits. Nuvo Intl Group Inc. today announced that pregnant moms can lease the FDA-cleared INVU wearable solution , a cloud-based pregnancy monitoring platform designed for use at home or at work, directly […]
(TSX-V:SAGA),(Boerse Frankfurt – Freiverkehr:20H),(OTC US:SAGMF),(Other OTC:SAGMF), VANCOUVER, British Columbia, Feb. 04, 2026 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral discoveries, is pleased to announce the assay results for the four (4) remaining diamond drill holes completed in
TORONTO, Feb. 04, 2026 (GLOBE NEWSWIRE) — Think of it like a mortgage calculator. It doesn't approve you for a loan; it simply helps you understand your fiscal position before you talk to the bank. Today on World Cancer Day, the Lung Health Foundation (LHF) introduces a more user-friendly lung cancer risk calculator that works
(NASDAQ:ZVRA), CELEBRATION, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced the presentation of four posters highlighting positive new data on MIPLYFFA(R) (arimoclomol) for the treatment of Niemann-Pick Disease Type C (NPC) at
(TSX-V:DMCU),(OTC US:DMCUF),(Other OTC:DMCUF),(Boerse Frankfurt – Freiverkehr:03E0.F), VANCOUVER, British Columbia, Feb. 04, 2026 (GLOBE NEWSWIRE) — Domestic Metals Corp. (the “Company” or “Domestic Metals“) – (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E0) engages TMC Geophysics to conduct 27 line-kilometers of electrical geophysics (Induced Polarization; “IP”) at the Smart Creek Project, Montana. The geophysical program is designed to
(NASDAQ:BIIB),(NASDAQ:IONS), Findings from DEVOTE support clinical benefits of the high-dose regimen of nusinersen (50 mg and 28 mg) in both treatment-naive individuals and those previously treated with 12 mg nusinersen The high-dose regimen of nusinersen also slowed neurodegeneration more rapidly, as measured by neurofilament, than the 12 mg regimen CAMBRIDGE, Mass., Feb. 04, 2026 (GLOBE
(NASDAQ:FSV),(TSX:FSV), Delivers Strong Consolidated Annual Earnings Operating highlights: Three months ended Year ended December 31 December 31 2025 2024 2025 2024 Revenues (millions) $ 1,383.4 $ 1,365.3 $ 5,497.5 $ 5,216.9 Adjusted EBITDA (millions) (note 1) 137.6 137.9 562.8 513.7 Adjusted EPS (note 2) 1.37 1.34 5.75 5.00 GAAP Operating Earnings 85.9 89.6 338.1 337.5
New polling released by Discovery Institute in time for Presidents Day reveals that most Americans still admire the American Founding. “The death of American patriotism appears to have been greatly exaggerated,” says political scientist Dr. John West, author of the new report How Americans View the American Founding. “Despite a torrent of negativity in recent
(NASDAQ:BFRG),(NASDAQ:BFRGW), New capabilities to be launched on March 25 Unique technology bolsters BullFrog AI's end-to-end AI intelligence workflow with a scenario-based decision engine Advances current AI decision tools by clearly defining clinical trial strategies and building diversified, risk-balanced R&D portfolios GAITHERSBURG, Md., Feb. 04, 2026 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW)
Two-year follow-up data demonstrate sustained benefit, including improvements in pain, fatigue and bone health, following single low dose of avigbagene parvec (FLT201) Robust improvements in lyso-Gb1, a surrogate biomarker for potential accelerated approval, in patients with elevated levels despite long-term treatment with existing therapies New patient-reported outcomes show improvements or maintenance of physical and mental